| Month | Product Name | Regulatory Filing Details | Connect |
|---|---|---|---|
| December | Atorvastatin Calcium Trihydrate [Form-I] | USA | ![Atorvastatin Calcium Trihydrate [Form-I]](/_next/image?url=%2Fimages%2Fhpapi-cont-1.png&w=32&q=75){kind=small} ![Atorvastatin Calcium Trihydrate [Form-I]](/images/hpapi-cont-1.png) |
| Nilotinib Premix (HPMC AS) | USA | | |
| Abemaciclib | Canada DMF | | |
| Sumatriptan Succinate | Japan DMF | | |
| Tafamidis Meglumine | Canada DMF | | |
| Rivaroxaban (Process-II) | USA | | |
| Naratriptan Hydrochloride | Russia DMF | | |
| Lomustine | Russia DMF | | |
| Fondaparinux Sodium | Saudi Arabia | | |
| Fondaparinux Sodium | EU | | |
| November | Dapagliflozin Propanediol | Singapore DMF | |
| Dapagliflozin Amorphous | Indonesia | | |
| Empagliflozin | Singapore DMF | | |
| Empagliflozin | Australia DMF | | |
| Carfilzomib | EU | | |
| Empagliflozin | Saudi Arabia | | |
| Pemetrexed Disodium | Saudi Arabia | | |
| Linagliptin | UK | | |
| October | Lurasidone hydrochloride | Taiwan DMF | |
| Tucatinib Hemiethanolate | India | | |
| Carfilzomib | Japan DMF | | |
| Dasatinib Monohydrate | Saudi Arabia | | |
| Empagliflozin | Malaysia DMF | | |
| Montelukast Sodium | Benin DMF | | |
| Naproxen Sodium | Malaysia DMF | | |
| Tizanidine Hydrochloride | CEP DMF Filed | | |
| September | Dapagliflozin Propanediol | Europe (CEP) | |
| Palonosetron Hydrochloride | Brazil DMF | | |
| Azacitidine | Saudi Arabia | | |
| Erubilin | Saudi Arabia | | |
| Valsartan, Essential Amorphous Form | Europe (CEP) | | |
| Palbociclib | Australia DMF | | |
| Gemcitabine Hydrochloride | Saudi Arabia | | |
| Mirabegron (alpha) | Saudi Arabia | | |
| Deucravacitinib | Brazil DMF | | |
| August | Tucatinib Copovidone ASD | USDMF | |
| Lenalidomide Povidone Premix | Egypt DMF | | |
| Edoxaban Tosylate Monohydrate | Brazil DMF | | |
| Ruxolitinib Hemifumarate | Australia DMF | | |
| Cetirizine Dihydrochloride | Egypt DMF | | |
| Apixaban | Singapore DMF | | |
| Apixaban | Sweden | | |
| July | Edoxaban Tosylate | USDMF | |
| Voriconazole | Russia DMF | | |
| Relugolix | India | | |
| Liraglutide | Saudi Arabia | | |
| Permethrin | Saudi Arabia | | |
| June | Docetaxel Anhydrous | Kenya | |
| Palonosetron Hydrochloride USP | Ethiopia | | |
| Cabazitaxel | Kenya | | |
| Tucatinib Hemiethanolate | Brazil DMF | | |
| Finerenone | Brazil DMF | | |
| May | Dapagliflozin Amorphous | Switzerland | |
| Nilotinib Hydrochloride Monohydrate | Indonesia | | |
| April | Bempedoic acid | Russia DMF | |
| March | Montelukast Sodium | Japan DMF | |
| Apixaban | Taiwan DMF | | |
| Palbociclib | Canada DMF | | |
| Deucravacitinib | USDMF | | |
| Finerenone | USDMF | | |
| Tucatinib | USDMF | | |
| Voclosporin | Brazil DMF | | |
| Lanreotide | Brazil DMF | | |
| Pomalidomide | | ||
| Vonoprazan Fumarate | Korea DMF | | |
| Palbociclib | Korea DMF | | |
| Ezetimibe (Unmicronized) | Korea DMF | | |
| Fexofenadine HCl (Form-1) -FXA4 process | CEP Submitted | | |
| Amlodipine Besylate (TY45) | CEP Submitted | | |
| Tucatinib Hemiethanolate | USDMF | | |
| Tizanidine Hydrochloride USP (TZN-Process) | USDMF | | |
| Enzalutamide Premix (20% w/w) | USDMF | | |
| Pazopanib HCl | EUDMF | | |
| Atorvastatin Calcium Trihydrate form-1 [ATO-3 process] | CEP Submitted | | |
| Ezetimibe (Micronized) | Korea DMF | | |
| February | Montelukast Sodium | Japan DMF | |
| Pioglitazone Hydrochloride | Canada DMF | | |
| Cabozantinib S- Maleate (N2 Form) | Korea DMF | | |
| Palbociclib | Singapore DMF | | |
| Ferric Carboxy Maltose | Saudi Arabia | | |
| January | Fexofenadine Form I | Brazil DMF | |
| Sacubitril/ Valsartan | Canada DMF | | |
| Dasatinib Monohydrate | Taiwan DMF | | |
| Pazopanib | Taiwan DMF | |
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。